Medication info
Nexmoclin Tablets 625mg (Amoxicillin·Clavulanate Potassium)

Nexmoclin Tablets 625mg (Amoxicillin·Clavulanate Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›500mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
Nexpharm Korea Co., Ltd.
Appearance
White or almost white oval film-coated tablets
Packaging
40 tablets (10 tablets/PTP X 4)
Approval status
Active

MFDS item code 201603126 · Approved 2016.05.31 · Insurance code 662503420

Summary

Main use
Treatment of respiratory and ear, nose, and throat infections, genitourinary infections, and skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
Adults: Administer orally 250 mg/125 mg of amoxicillin/potassium clavulanate per dose 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Creatinine clearance 10 ~ 30 mL/min: Administer 250 ~ 500 mg of amoxicillin orally per dose every 12 hours. Creatinine clearance 10 mL/min or less: Administer 250 mg of amoxicillin per dose every 24 hours, ensuring that the dose is not exceeded. However, for dental infections, administer 250 mg of amoxicillin per dose 3 times daily for 5 days.
Child dose
Children 12 years of age or older or weighing 40 kg or more: Administer orally 250 mg/125 mg of amoxicillin/potassium clavulanate per dose 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children with renal impairment: Reduce the dose in the same manner.

Ingredients

Manufacturer
Nexpharm Korea Co., Ltd.

Efficacy & effects

Treatment of respiratory and ear, nose, and throat infections, genitourinary infections, and skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infections
View approved original text

This medication is used to treat various kinds of bacterial infections. It is effective for respiratory-related infections such as acute and chronic bronchitis, pneumonia, empyema, and lung abscesses. It is also used for upper respiratory infections, including tonsillitis, sinusitis, and otitis media. It aids in the treatment of urogenital infections, including cystitis, urethritis, pyelonephritis, and gonorrhea. It can also be applied to skin and soft tissue infections, osteomyelitis, and dental infections. It is widely used for the treatment of various infectious diseases.

How to take

Adult dose

Adults: Administer orally 250 mg/125 mg of amoxicillin/potassium clavulanate per dose 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Creatinine clearance 10 ~ 30 mL/min: Administer 250 ~ 500 mg of amoxicillin orally per dose every 12 hours. Creatinine clearance 10 mL/min or less: Administer 250 mg of amoxicillin per dose every 24 hours, ensuring that the dose is not exceeded. However, for dental infections, administer 250 mg of amoxicillin per dose 3 times daily for 5 days.

Child dose

Children 12 years of age or older or weighing 40 kg or more: Administer orally 250 mg/125 mg of amoxicillin/potassium clavulanate per dose 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children with renal impairment: Reduce the dose in the same manner.

Precautions

This drug is a beta-lactam antibiotic and should not be administered to patients who have had allergic reactions to penicillin or cephalosporin drugs. In particular, caution is needed for patients with infectious mononucleosis or lymphocytic leukemia as they are at a higher risk of rash. Patients with a history of liver dysfunction or jaundice should also avoid its use due to the risk of recurrence. Patients with liver impairment or moderate to severe kidney impairment may experience increased drug concentration, necessitating dosage adjustment and monitoring. Care should be taken when used by patients with allergic tendencies, those who have difficulty with oral intake, elderly patients, and those in poor general condition. Gastrointestinal adverse reactions such as diarrhea, vomiting, and abdominal pain may occur, and if severe diarrhea or abdominal pain develops, medication should be discontinued immediately. Liver dysfunction may also occur, so liver function tests should be performed regularly in elderly patients, males, and during prolonged use exceeding 14 days. Severe skin reactions such as rashes, itching, and in serious cases, Stevens-Johnson syndrome, may appear, and if symptoms occur, the medication should be stopped immediately and medical advice should be sought. Hematological anomalies such as leukopenia, anemia, and thrombocytopenia may occur rarely, so vigilance for unusual symptoms is necessary. Central nervous system reactions may include agitation, anxiety, dizziness, and rare seizures; if neurological symptoms appear, consultation with healthcare professionals is required. Acute kidney failure or nephritis may occur rarely, necessitating kidney function testing. This medication may affect intestinal flora and lead to dysbiosis such as stomatitis and candidiasis. There may be a tendency to bleed due to vitamin K deficiency, so caution is necessary if bleeding symptoms occur. Long-term use of this drug may lead to the development of resistant bacteria, so it is recommended to administer for the minimum duration after susceptibility testing. Patients with hypersensitivity to penicillin may experience severe allergic reactions, requiring monitoring after administration and immediate treatment in emergency situations. There is a risk of antibiotic-associated pseudomembranous colitis, so if diarrhea or abdominal pain is severe, use should be discontinued and medical attention sought. It is safest for women in the early stages of pregnancy or those capable of becoming pregnant to avoid this medication. Caution is needed during breastfeeding as adverse reactions may occur in infants. Use is recommended for children aged 12 years and older or those weighing over 40 kg, and it should be given cautiously to the elderly due to the increased risk of adverse reactions from decreased physiological functions. This drug may interact with other medications, particularly anticoagulants and certain antibiotics. In cases of overdose, gastrointestinal symptoms, renal failure, and seizures may appear, requiring immediate cessation of use and appropriate treatment.

Side effects

  • Diarrhea
  • pseudomembranous colitis
  • dyspepsia
  • stomatitis
  • gastritis
  • glossitis
  • black hairy tongue
  • nausea
  • vomiting
  • loss of appetite
Show 82 more
  • abdominal pain
  • abdominal distention
  • constipation
  • colonic pain
  • hyperacidity
  • melena
  • xerostomia
  • acute pancreatitis
  • candidiasis
  • antibiotic-induced colitis
  • severe colitis with blood in stool
  • elevated AST
  • elevated ALT
  • elevated ALP
  • elevated LDH
  • elevated serum bilirubin
  • hepatitis
  • cholestatic jaundice
  • pruritus
  • erythema multiforme
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • vesicular peeling dermatitis
  • acute generalized pustular psoriasis
  • eosinophilia
  • angioedema
  • anaphylaxis
  • serum sickness
  • hypersensitivity vasculitis
  • dyspnea with bronchospasm
  • laryngeal edema
  • anaphylactic shock
  • reversible leukopenia
  • thrombocytopenia
  • hemolytic anemia
  • anemia
  • thrombocytopenic purpura
  • eosinophilia
  • leukemia
  • agranulocytosis
  • lymphocytopenia
  • thrombocytosis
  • bone marrow suppression
  • prolonged bleeding time
  • prolonged prothrombin time
  • mucosal candidiasis
  • vaginal itching
  • vaginal burning
  • increased discharge
  • restlessness
  • anxiety
  • behavior changes
  • confusion
  • drowsiness
  • insomnia
  • reversible hyperactivity
  • dizziness
  • headache
  • convulsions
  • anti-spasmodic
  • fever
  • clouding of consciousness
  • aseptic meningitis
  • acute renal failure
  • interstitial nephritis
  • hematuria
  • crystalluria
  • symptoms of vitamin K deficiency
  • symptoms of vitamin B complex deficiency
  • linear IgA disease
  • taste disturbances
  • malaise
  • dermatitis
  • oral edema
  • gastric pain
  • fluid and electrolyte imbalance
  • rash
  • hyperactivity
  • drowsiness
  • renal failure
  • interstitial cerebral convulsions
  • hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is contained in a sealed container to prevent moisture ingress. Therefore, it is advisable to store it in a cool place at a temperature between 1 and 25 degrees Celsius, avoiding moisture and direct sunlight.

Appearance and packaging

Appearance

White or almost white oval film-coated tablets

Package unit

40 tablets (10 tablets/PTP X 4)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.